Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
BC Platforms Expands Data Partner Network with Major Brazilian Cardiovascular Health Institution
BC Platforms (BCP), a global leader in healthcare data management and analytics, today announces the […]
CardiaCare Names Ken Nelson Chairman of its Board of Directors
CardiaCare, a clinical-stage digital therapeutic company developing the world’s first non-invasive, neuromodulation wearable for atrial […]
Abbott Announces US and European Approvals for New Technologies to Support Effective Treatment for Abnormal Heart Rhythms
Abbott has announced two approvals as part of its growing suite of electrophysiology products in […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more